A
Alzeca Biosciences
Healthcare diagnostic company
About Alzeca Biosciences
Alzeca Biosciences is a medical diagnostics company specializing in the development of advanced imaging agents for the early detection of neurodegenerative diseases, with a primary focus on Alzheimer's disease. The company is developing a proprietary, targeted MRI contrast agent that aims to identify the beta-amyloid plaques associated with early-stage Alzheimer's. This technology is designed to work with conventional MRI systems, potentially offering a more accessible and cost-effective diagnostic tool compared to other advanced imaging methods.
The company's business model centers on the research and development of these novel imaging agents, with the goal of bringing them to market to improve early diagnosis and patient outcomes. By enabling earlier detection, Alzeca's technology could help facilitate timely therapeutic intervention and disease management. The company serves the healthcare and medical diagnostics market, with a focus on neurological disorders.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 5
- Open positions
- None listed
- Dealroom signal
- 54.1/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Alzheimers Disease, Spinout, DT and LS, science-based
- Technology
- Artificial Intelligence, Big Data, Deep Tech, Computer Vision
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AEquity / VC | Oct 2019 | $0 | — | Undisclosed | — |
| SERIES A✓Equity / VC | Aug 2017 | $11M | $44M | Dolby Family Ventures | — |
Growth signals
Latest recorded traffic for Alzeca Biosciences is 180 monthly website visits, up 200% over the last three months. Alzeca Biosciences's team declined 16.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Alzeca Biosciences in the Houston ecosystem
The Alzeca Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Dolby Family Ventures
Other known investors3 additional known investors
University of Texas Health Science Center at Houston
Central Texas Angel Network
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Alzeca Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Alzeca Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










